Is Mesalamine Capsule, Extended Release (Pentasa) in shortage?
Mesalamine Capsule, Extended Release is listed by FDA as being discontinued by at least one maker (updated Sep 16, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Pentasa, Capsule, Extended Release, 250 mg (NDC 54092-189-81)
Product is anticipated to be available until December 31, 2027
Maker contact: 877 825 3327
- Pentasa, Capsule, Extended Release, 500 mg (NDC 54092-191-12)
Product is anticipated to be available until December 31, 2027
Maker contact: 877 825 3327
- Mesalamine, Capsule, Extended Release, .375 g (NDC 0378-1375-78)
Discontinuation of the manufacture of the drug
Maker contact: 800-796-9526
FDA recalls of Mesalamine
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Mesalamine Capsule, Extended Release:
- SUN PHARMACEUTICAL INDUSTRIES INC recalls Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical
- SUN PHARMACEUTICAL INDUSTRIES INC recalls Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily, Distributed by:
- Teva Pharmaceuticals USA recalls Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: Actavis
- Teva Pharmaceuticals USA recalls Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL,
- Shire PLC recalls Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US Inc.,
Mesalamine Capsule, Extended Release shortage questions
Is Mesalamine Capsule, Extended Release (Pentasa) in shortage?
Mesalamine Capsule, Extended Release is listed by FDA as being discontinued by at least one maker (updated Sep 16, 2026).
What should I do if I can’t get Mesalamine Capsule, Extended Release?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.